Company: Self Employed
Location: East Bridgewater, Massachusetts, United States
Robert J. Miller, PhD, Consultant, has been recognized by Marquis Who’s Who Top Executives for dedication, achievements, and leadership in medical research.
Dr. Miller had his sights set on a career in science, specifically marine biology, since his youth, and in 1980 he achieved a BS in chemistry and marine chemistry from Long Island University’s Southampton campus. He went on to earn a PhD in chemistry from the Rensselaer Polytechnic Institute in 1985, in which he conducted research requiring a thorough knowledge of synthetic organic, biological and physical chemistry in the mechanistic elucidation of enzymatic reactions responsible for regulating cell growth, such as spermidine and spermine synthases. He made it his goal to find a way to require the composition of several programs for interfacing laboratory instruments to personal computers in order to do kinetic analysis.
Continuing to pursue his passions and interests, in 1987, Dr. Miller was a postdoctoral associate in chemistry at the Pennsylvania State University. In his postdoctoral research at the laboratory of Professor Stephen J. Benkovic, Dr. Miller studied the design and synthesis of novel mechanism-based irreversible inhibitors for rat liver phenylalanine hydroxylase. He was also involved in a project designed to clone that same enzyme from the bacterial species chromobacterium violaceum.
Specializing in polymers, biomedicine, new product development, commercialization and more, Dr. Miller currently serves as a consultant in his field. He previously worked for Sanofi, a medical research and development consultancy, as senior director of Genzyme Corporation where he dealt with research, development, manufacturing and marketing of therapeutic health care solutions, as well as topics including diabetes solutions, human vaccines, innovative drugs, consumer health care, emerging markets, animal health and rare diseases. He notably managed a group of 12 scientists and engineers, who focused on developing new materials that affect the inflammatory process at the placement site.
Dr. Miller is associated with AMPIC and the American Chemical Society, and also contributes to charity work with Doctors Without Borders and the Multiple Sclerosis Association of America. In five years’ time, Dr. Miller sees himself in retirement having passed the reigns of his consultancy to someone else, but always remaining inquisitive and supportive of scientific developments. In his free time, he enjoys gardening and traveling.
Contact Dr. Miller: